In the BioHarmony Drug Report Database
Carbaglu (carglumic acid) is a small molecule pharmaceutical. Carglumic acid was first approved as Carbaglu on 2003-01-24. It is used to treat hyperammonemia in the USA. It has been approved in Europe to treat hyperammonemia, inborn errors amino acid metabolism, and propionic acidemia.
Image (chem structure or protein)